The Myth of Case Studies and Best Practices

The Myth of Case Studies and Best Practices An article appeared in The Wall Street Journal about Pfizer’s development of the COVID-19 vaccine. I'm using Pfizer’s good work to contrast how hard it is to know when good work is being done. This article talks about the incredible drive and determination of pharmaceutical companies to roll out a vaccine in less than a year. It focuses on Pfizer, but there will be case studies about many pharmaceutical companies around the world who were successful at producing a vaccine in a short period of time. The article shows how Pfizer’s CEO faced the difficulty of pushing his teams to find faster ways of doing things without breaking any rules or crossing any ethical gray lines. Case studies on solving a problem employees don’t yet know how to solve It’s very laudatory and positive about what Pfizer and other pharmaceutical companies have done. It's amazing to see how they did it, the challenges they faced and how they stepped up to those challenges. But there's a reason why this theme is called the myth of case studies and best practices. The business press has many stories about successful companies, whether it's Tesla, whether it's SpaceX, and companies that…